PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Aug-2024 Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48% AccessWire
08-Aug-2024 Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update Immunic AG
08-Aug-2024 NanoViricides Provides an Update on Its Clinical Program and Strategy - NV-387 Could be As Revolutionary as Antibiotics AccessWire
08-Aug-2024 SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers AccessWire
08-Aug-2024 First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed RHÖN-KLINIKUM Aktiengesellschaft
08-Aug-2024 Europe Investment Management Regulatory Reporting Market Analysis, Size, Share, Growth, Trends Forecasts 2023-2030 Metastat Insight and Technologies Pvt. Ltd.,
08-Aug-2024 Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb AccessWire
08-Aug-2024 Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb Evotec SE
08-Aug-2024 Kuros Biosciences Reports First Half of 2024 Results AccessWire
08-Aug-2024 Kuros Biosciences Reports First Half of 2024 Results Kuros Biosciences AG
07-Aug-2024 Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results AccessWire
07-Aug-2024 Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024 AccessWire
07-Aug-2024 CLINIGEN ACQUIRES KINESYS CONSULTING TO BOLSTER REGULATORY AFFAIRS EXPERTISE Clinigen
07-Aug-2024 XF-73 treatment of MRSA burn wound infection prevents bacterial invasion of the bloodstream Destiny Pharma plc
07-Aug-2024 CellProthera begins long-term observational study to demonstrate safety and efficacy of ProtheraCytes® cell therapy in acute myocardial infarction CellProthera
07-Aug-2024 New results from AlzeCure's pain project TrkA-NAM presented at the pain conference IASP 2024 AlzeCure Pharma AB
07-Aug-2024 Release Therapeutics Secures CHF 3.3 Million in Seed Funding Release Therapeutics
07-Aug-2024 Velocity appoints ICON exec Rachael Buck Ph.D. as Head of U.K. Velocity Clinical Research
07-Aug-2024 Kyowa Kirin International and NewBridge Pharmaceuticals enter into agreement to improve access to medicines for rare disease patients across Middle East and North Africa Kyowa Kirin International
07-Aug-2024 Lindus Health Unveils “All-in-One Dermatology CRO” Offering for Dermatology Clinical Trials Lindus Health